破裂腹主动脉瘤修复术后ICU 48小时生存预测:新评分的外部验证多中心研究
本研究基于单中心2010-2017年78例破裂腹主动脉瘤患者数据,开发了纳入48小时ICU血流动力学不稳定和乳酸水平的术后动脉瘤评分(PAS),用于预测30天死亡率。PAS在3个独立血管外科中心的外部验证中显示对48小时存活患者的预测能力显著优于VSGNE评分(AUC 0.820 vs 0.782,P=0.027)。
要点
- PAS评分纳入48小时血流动力学不稳定和乳酸水平,预测30天死亡率优于VSGNE评分。
- 48小时ICU存活患者30天死亡率降至27.6%,PAS有助于识别可避免的延长治疗。
- 尽管术前预测因素存在,作者科室政策仍对所有病例尝试手术修复。
核心结论
- PAS评分在48小时ICU存活患者中预测30天死亡率显著优于VSGNE评分,并在独立中心获得外部验证。
研究设计与样本
- 回顾性单中心研究,纳入2010年1月至2017年12月78例破裂腹主动脉瘤患者开发评分,随后在3个独立血管外科中心进行外部验证。
主要发现
- EVAR组和开放修复组术中死亡率分别为0%和24.6%(P=0.012)。
- 开放修复组和EVAR组30天死亡率分别为50%和33%。
- 48小时存活患者30天死亡率降至27.6%。
- 术前预测因素包括吸烟(P=0.004)、血流动力学不稳定(P=0.004)和国际标准化比值升高(P<0.0001)。
- 荷兰动脉瘤评分和VSGNE评分也是显著预测因素(ROC AUC分别为0.89和0.79,P<0.0001)。
关键数值与推荐
- 48小时ICU期间,高乳酸水平、高SOFA评分、需要血液透析技术和血流动力学不稳定是30天死亡率的显著风险预测因素(P<0.05)。
- VSGNE评分经修改纳入48小时血流动力学不稳定和乳酸水平两个变量,形成新评分PAS。
- 48小时存活患者中,PAS的AUC为0.852,VSGNE为0.775(P=0.039)。
- 外部验证中,PAS的AUC为0.820,VSGNE为0.782(P=0.027)。
临床怎么用
- 对于破裂腹主动脉瘤修复术后48小时ICU存活患者,可使用PAS评分预测30天死亡率,辅助识别可能避免的不必要延长治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Ruptured abdominal aortic aneurysm (rAAA) remains a critical life-threatening condition. We aimed to evaluate rAAA management in our center focusing on predictors of mortality at 48 hr of intensive care unit (ICU) and to develop a new mortality prediction score considering data at 48 hr postprocedure. External validation of the modified score with patient data from independent vascular surgery centers was subsequently pursued. METHODS: Clinical data of all patients admitted in our center from January 2010 to December 2017 with the diagnosis of rAAA were retrospectively reviewed for the development of the mortality prediction score. Subsequently, clinical data from patients admitted at independent centers from January 2010 to December 2017 were reviewed for external validation of the score. Statistical analysis was performed with SPSS Version 25. RESULTS: A total of 78 patients were included in the first part of the study: 21 endovascular aneurysm repairs (EVARs), 56 open repairs (ORs), and 1 case of conservative management. Intraoperative mortality in EVAR and OR groups was 0% vs. 24.6%, respectively (P = 0.012). Thirty-day mortality reached 50% and 33% in the OR and EVAR groups. For patients alive at 48 hr, 30-day mortality diminished to 27.6%. Several preoperative predictors of outcome were identified: smoking (P = 0.004), hemodynamic instability(P = 0.004), and elevated international normalized ratio (P < 0.0001). Dutch Aneurysm Score and Vascular Study Group of New England Score (VSGNE) were also significant predictors of outcome (area under the receiver operating characteristic curve [ROC AUC] 0.89 and 0.79, respectively; P < 0.0001). At 48 hr of ICU stay, high lactate level, high Sequential Organ Failure Assessment score, need for hemodyalitic technique, and hemodynamic instability were significant risk predictors for 30-day mortality (P < 0.05). VSGNE score was modified with the inclusion of 2 variables: hemodynamic instability and lactate level at 48 hr and a new score was attained-Postoperative Aneurysm Score (PAS). Comparing AUC for VSGNE and PAS for patients alive at 48 hr, the latter was significantly better (AUC 0.775 vs. 0.852, P = 0.039). The PAS was applied and validated in 3 independent vascular surgery centers (AUC VSGNE 0.782 vs. AUC PAS 0.820, P = 0.027). CONCLUSIONS: Despite recent evidence on preoperative predictors of survival in an era when both EVAR and OR are available, emergent decision to withhold life-saving treatment will always be extremely difficult. Therefore, the policy in our department is to try surgical repair in all cases. It remains important, however, to identify whether late deaths can be predicted, so that unnecessary prolonged treatment can be avoided. A PAS was delineated predicting 30-day mortality significantly better in patients alive at 48 hr. The score was externally applied and validated in independent centers, corroborating the score's usefulness.
引用
- Pires Coelho A, Lobo M, Brandão JP, et al. Prediction of Survival after 48 Hours of Intensive Unit Care following Repair of Ruptured Abdominal Aortic Aneurysm-Multicentric Study for External Validation of a New Prediction Score for 30-Day Mortality. Ann Vasc Surg. 2019. PMID: 31075455. doi:10.1016/j.avsg.2019.02.026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。